gDNA Q-PCR for clinical monitoring of CML

Cell Cycle. 2015;14(23):3659-60. doi: 10.1080/15384101.2015.1006053.

Authors

Giovanni Porta¹, Ilaria Stefania Pagani^{1

2}, Cristina Pirrone¹

Affiliations

¹ a Department of Clinical and Experimental Medicine ; University of Insubria ; Varese , Italy.
² b Department of Experimental Medicine and Surgery ; Tor Vergata University ; Rome , Italy.

No abstract available

Publication types

Editorial

MeSH terms

Disease Progression
Genetic Markers
Humans
Imatinib Mesylate / administration & dosage
Imatinib Mesylate / therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
Polymerase Chain Reaction / methods
Protein Kinase Inhibitors / administration & dosage
Protein Kinase Inhibitors / therapeutic use
RNA, Messenger / metabolism
Recurrence
Remission Induction
Treatment Outcome

Substances

Genetic Markers
Protein Kinase Inhibitors
RNA, Messenger
Imatinib Mesylate